Doing Life Sciences Deals in 2024
JD Supra: Mergers
APRIL 23, 2024
Nearly one hundred life sciences professionals convened at Mintz’s Boston office last week for an event we hosted in partnership with the LES (Licensing Executives Society).
JD Supra: Mergers
APRIL 23, 2024
Nearly one hundred life sciences professionals convened at Mintz’s Boston office last week for an event we hosted in partnership with the LES (Licensing Executives Society).
JD Supra: Mergers
MAY 2, 2024
Dealmaking in the life sciences sector comes with characteristics not typically seen in more traditional mergers and acquisitions (M&A). Deals often involve negotiating around complexities associated with both the unique nature of assets of life sciences companies and the unique industry ecosystem that brings these assets to life.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
JD Supra: Mergers
APRIL 18, 2024
On March 26, 2024, Skadden hosted a discussion on key developments in antitrust enforcement in the pharmaceuticals and life sciences sectors. By: Skadden, Arps, Slate, Meagher & Flom LLP
JD Supra: Mergers
JANUARY 5, 2024
In November, we were delighted to once again host our annual European Health & Life Sciences Symposium in Paris.
Advertisement
Many application teams leave embedded analytics to languish until something—an unhappy customer, plummeting revenue, a spike in customer churn—demands change. But by then, it may be too late. In this White Paper, Logi Analytics has identified 5 tell-tale signs your project is moving from “nice to have” to “needed yesterday.".
JD Supra: Mergers
APRIL 16, 2024
Concurrent with the capital markets regaining momentum, 2024 to date has shown robust merger and acquisition (M&A) activity, with notable growth of close to 11% in life sciences M&A activity compared to 2023. By: McDermott Will & Emery
JD Supra: Mergers
NOVEMBER 10, 2023
This report series examines quarterly trends in life sciences venture investment. Key findings for Q3 2023 include: Life sciences VC deal value in Q3 2023 totaled $7.7 billion, representing an uptick from last quarter across fewer deals. Total deal value has grown each quarter in 2023 for a year-to-date (YTD) total of $21.4
Advertisement
You’ll learn: The challenges of missing or outdated analytics How buying an analytics solution can bring new life and revenue to older applications The value of embedding analytics to users, development teams, and the bottom line
Let's personalize your content